Key takeaways
- Acetyl hexapeptide-8 is the active ingredient in a labeled topical product called Stretch Marks cream.
- The label describes it as intended to reduce the appearance of stretch marks and support skin elasticity.
- No boxed warning appears on the label.
- Six trials involving acetyl hexapeptide-8 are registered, spanning cosmetic and ophthalmic research contexts.
- No FAERS reports are currently listed for this compound in the data reviewed.
What acetyl hexapeptide-8 is
Acetyl hexapeptide-8 is a synthetic peptide with a molecular weight near 887 (PubChem CID 71587772). Its label lists the pharmacologic class as a non-standardized food allergenic extract. No mechanism of action is described in the label data available.
What acetyl hexapeptide-8 is approved for
The FDA label covers a topical product marketed under the brand name Stretch Marks cream. It is described as intended to reduce the appearance of scars and stretch marks and to support skin repair and elasticity. The label does not carry a boxed warning.
What the evidence shows
Six trials involving acetyl hexapeptide-8 are registered. One completed study examined its topical use in relation to the cosmetic appearance of oily skin. Separate completed studies looked at the compound, referred to as AH8 or Argireline, in blepharospasm (phase 1/2) and in periorbital wrinkles (phase 3).